Nurix Therapeutics, Inc. (NRIX)
16.50
-0.43
(-2.54%)
USD |
NASDAQ |
May 05, 11:47
Nurix Therapeutics Total Liabilities (Quarterly) : 155.24M for Feb. 28, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 120.24M |
| Scholar Rock Holding Corp. | 158.78M |
| Stoke Therapeutics, Inc. | 65.98M |
| Immunome, Inc. | 48.84M |
| Innoviva, Inc. | 462.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 636.13M |
| Shareholders Equity (Quarterly) | 480.89M |
| Debt to Equity Ratio | 0.122 |
| Current Ratio | 6.013 |
| Net Debt Paydown Yield | -0.37% |